FDA Approved: BAXDELA — Original Application (Melinta Therapeutics, LLC)

View source ↗

Summary

FDA approved Baxdela (delafloxacin meglumine) from Melinta Therapeutics. The approval covers the original New Drug Application NDA208610 for the treatment of ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections

Drugs mentioned

• BAXDELA (delafloxacin meglumine)

Snippet

ORIG AP for BAXDELA (DELAFLOXACIN MEGLUMINE)